vimarsana.com

Latest Breaking News On - Medical dunlop - Page 1 : vimarsana.com

国产冠脉球囊匆匆"带量" 质量隐患已引起监管重视 _ 东方财富网

国产冠脉球囊匆匆"带量" 质量隐患已引起监管重视 _ 东方财富网
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

China
Taiwan
Shanghai
Country-drug-department
Country-drug
Shanghai-sun
Boston-science-mao
China-medical
Medical-dunlop
Novo-medical
Shiner-medical

国产冠脉球囊匆匆"带量" ,质量隐患已引起监管重视

国产冠脉球囊匆匆"带量" ,质量隐患已引起监管重视
yicai.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yicai.com Daily Mail and Mail on Sunday newspapers.

China
Taiwan
Shanghai
Country-drug-department
Country-drug
Shanghai-sun
Boston-science-mao
China-medical
Medical-dunlop
Novo-medical
Shiner-medical

国产冠脉球囊匆匆"带量" 质量隐患已引起监管重视|导管|微创

国产冠脉球囊匆匆"带量" 质量隐患已引起监管重视|导管|微创
163.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 163.com Daily Mail and Mail on Sunday newspapers.

China
Taiwan
Shanghai
Country-drug-department
Country-drug
Shanghai-sun
Boston-science-mao
China-medical
Medical-dunlop
Novo-medical
Shiner-medical

终于反弹了,医疗器械ETF(159883)也企稳反弹_乐普医疗(300003)股吧_东方财富网股吧

终于反弹了,医疗器械ETF(159883)也企稳反弹_乐普医疗(300003)股吧_东方财富网股吧
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

China
Thailand
Zhejiang
Switzerland
Thai
English-division
Goldman-sachs
Dunlop-medical
Medical-dunlop
Step-switzerland-medical
Step-switzerland

接连两笔收购 远大医药继续"跨界"器械 但布局点也是巨头重仓之地 怎么破? _ 东方财富网

以原料药起家的老牌药企远大医药最近连续在医疗器械领域出手。8月以来,它先后宣布了两笔收购:最多以7200万美元取得海外器械公司FastWave的100%股权,以1200万美元取得CoRISMA约22.2%的股权,以及其产品在亚太地区多个国家的商业化权益。这是行业又一家从药跨到医疗器械的公司。

China
Germany
Switzerland
Belgium
Asia-pacific
Yale-university
Junior
It-holdings
Office-medical
Guo-medical
Medical-dunlop
China-medical

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.